Establishing culture systems for the expansion of adult neural stem cells (aNSCs) allows for the examination and application of aNSCs for therapy. The subcallosal zone (SCZ) has recently been recognized as a novel neuroblast-forming region in adult mice. Here, methods for the isolation, expansion, and differentiation of SCZ-aNSCs are described.
Adult neural stem cells (aNSCs) can be used for the regeneration of damaged brain tissue. NSCs have the potential for differentiation and proliferation into three types of cells: neurons, astrocytes, and oligodendrocytes. Identifying aNSC-derived regions and characterizing the aNSC properties are critical for the potential use of aNSCs and for the elucidation of their role in neural regeneration. The subcallosal zone (SCZ), located between white matter and the hippocampus, has recently been reported to contain aNSCs and continuously give rise to neuroblasts. A low percentage of aNSCs from the SCZ is differentiated into neurons; most cells are differentiated into glial cells, such as oligodendrocytes and astrocytes. These cells are suggested to have a therapeutic potential for traumatic cortical injury. This protocol describes in detail the process to generate SCZ-aNSCs from an adult mouse brain. A brain matrix with intervals of 1 mm is used to obtain the SCZ-containing coronal slices and to precisely dissect the SCZ from the whole brain. The SCZ sections are initially subjected to a neurosphere culture. A well-developed culture system allows for the verification of their characteristics and can increase research on NSCs. A neurosphere culture system provides a useful tool for determining proliferation and collecting the genuine NSCs. A monolayer culture is also an in vitro system to assay proliferation and differentiation. Significantly, this culture system provides a more homogenous environment for NSCs than the neurosphere culture system. Thus, using a discrete brain region, these culture systems will be helpful for expanding our knowledge about aNSCs and their applications for therapeutic uses.
NSCs have characteristics of self-renewal and multiple-lineage differentiation. To confirm these properties, a neurosphere culture system has widely been used. The neurosphere culture system was developed in the early 1990s and served as a standard stem cell culture system1. Depending on self-renewal potency, NSCs continuously proliferate and generate a cell mass in a suspension culture. The number of cells and the size of the neurosphere are considered to be closely associated with the proliferation properties of the NSCs. Monolayer cultures are also widely used for the maintenance and differentiation of NSCs. Compared to the neurosphere culture, the monolayer culture system provides better homogenous maintenance and expansion of NSCs2. These two well-developed culture systems have contributed to the characterization of aNSCs in vitro.
NSCs reside in different brain regions, such as the subventricular zone (SVZ) of the lateral ventricle and the subgranular zone (SGZ) of the hippocampus3-5. The subcallosal zone (SCZ) of the caudal subcortical white matter is recognized as a novel neurogenic region6-8. It was recently reported that the SCZ-aNSCs have therapeutic potential in traumatic brain injury9. Compared to other neurogenic regions, the SCZ resides along the subcortical white matter. In the human brain, subcortical white matter occupies a larger region than in the mouse brain10. Therefore, an understanding of the characteristics of SCZ-aNSCs using an in vitro culture system is important in order to promote the potential use of these cells for neural regeneration. Precise dissection of the desired brain region is required to rule out possible contamination by unwanted regions containing active or quiescent NSCs. For instance, aNSCs in non-neurogenic regions can be activated and produce new neural cells in injured brains or during in vitro culturing11. To obtain NSCs from the SCZ, cells were collected from brain slices containing the SCZ. Then, a careful micro-dissection of the SCZ region was performed using a fine needle. To generate the neurosphere from the SCZ, micro-dissected SCZ tissue chunks were dissociated into single cells and then cultured as a suspension in the presence of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF). After SCZ-aNSCs form neurospheres, they also can be maintained as neurospheres or monolayers for expansion. This procedure also demonstrates immunostaining processes with various markers for the detection of NSCs and their progeny after their expansion and differentiation in a monolayer culture. Here, a visual protocol of the SCZ-aNSC culture system is presented. This protocol contains detailed instructions for the micro-dissection of the SCZ region and for the maintenance and passaging of the cells.
1. Preparation of Materials and Culture Medium
2. Isolation and Dissociation of the Adult SCZ
3. Subcallosal Zone-derived Adult Neural Stem Cell Culture
4. Passaging of NSCs as Neurospheres and to Monolayer Cultures
5. Differentiation of Subcallosal Zone-derived Adult Neural Stem Cells
6. Immunostaining Adult Neural Stem Cells and Differentiated Progenitors
Defining the culture system for aNSCs from the unknown neurogenic region is essential for understanding these cells and for developing their potential use in brain repair12. It is known that NSCs in different developmental stages or in different regions behave differently3,4. Recently, it was reported that SCZ-derived cells exhibit differential potentials for neuronal differentiation in vivo and in vitro compared to SVZ-derived cells7-9. Therefore, to precisely isolate each neurogenic region, brain slices that include the SCZ were dissected using a 1 mm brain matrix (Figure 1A). After 8 days of culture with growth factors, aNSCs derived from the SCZ can form neurospheres, in which the cells can be subsequently maintained (Figure 1B).
Since a subset of NSCs in the neurospheres may be spontaneously differentiated13, a monolayer culture system is also helpful for the maintenance of the relatively homogeneous population of SCZ-aNSCs. Growth factors and dissociation enzymes such as trypsin do not easily permeate deep inside of the neurosphere14,15. Monolayer cultures provide more even conditions for the expansion of NSCs. From primary neurospheres, SCZ-aNSCs were dissociated into single cells by a digestion buffer treatment. One day after cell seeding, aNSCs were attached to the coated plate and exhibited cell proliferation (Figure 2A). To confirm their potency of proliferation, BrdU was added into the media. After incubation with BrdU for 2 hr, cells were readily stained with anti-BrdU (a marker for proliferation) and anti-Nestin (a marker for neural stem cells) antibodies, indicating that SCZ-aNSCs are actively proliferating and maintaining the key properties of stem cells (Figure 2B). Accordingly, they did not exhibit markers for differentiated cells, such as EGFR (expressed in transiently-amplifying cells) and DCX (expressed in neuroblasts) (Figure 2C).
To confirm the multiple differentiation potential of SCZ-aNSCs, growth factors were removed from the culture media. After 6 days, cells were immunostained with various makers for differentiated cells. To exhibit the different progenies of aNSCs, markers for neurons (Tuj1), astrocytes (GFAP), and oligodendrocytes (O4) were employed; all of these cell types were generated from the SCZ-aNSCs (Figure 3).
Figure 1: Isolation of the SCZ region and formation of the neurosphere. (A) Procedure for the dissection of the SCZ region from the adult mouse brain. To culture the SCZ-aNSCs, an 8 week-old mouse brain is placed onto a brain matrix (1 mm intervals). After sectioning, 1 mm brain slices that included the SCZ region (2-3 mm from bregma) were dissected (indicated by the red dotted line). (B) Neurosphere formation. Eight days after the in vitro culture, primary neurospheres (passage 0) were formed and passaged. Please click here to view a larger version of this figure.
Figure 2: Maintenance of the SCZ-aNSCs as a monolayer culture. (A) One day after seeding the dissected cells, SCZ-aNSCs were attached and expanded onto a coated dish in a monolayer manner (left). Three days after maintenance, the number of SCZ-aNSCs was increased (right). (B) Immunostaining with BrdU (red, a marker for proliferating cells), Nestin (green, a marker for neural stem cells), and Hoechest33343 (blue, a marker for nuclei). (C) Immunostaining with neural stem/progenitor cell markers Nestin (red, a marker for type B neural stem cells), EGFR (green, a marker for type C transient-amplifying cells), and DCX (blue, a marker for type A neuroblasts). Nuclei were counterstained with Hoechest33343 (white). Please click here to view a larger version of this figure.
Figure 3: Immunostaining of the differentiated cells from the SCZ-aNSCs. Immunostaining with differentiation markers Tuj1 (green, a marker for immature neurons), O4 (red, a marker for oligodendrocytes), and GFAP (yellow, a marker for astrocytes). Magnified images are shown as insets. Hoechest33343 (blue) was used for counter-staining the nuclei. Please click here to view a larger version of this figure.
This paper describes a detailed protocol to generate NSCs from the adult mouse SCZ and to maintain them for various applications. There are three critical steps for establishing the in vitro culture system needed to purify and expand SCZ-NSCs. First, it is important to ensure that the SCZ region is precisely dissected out from other potential neurogenic regions (Figure 1B). Thick and precise sections containing the SCZ regions were obtained with a 1 mm interval brain matrix, and then a fine needle was used for the micro-dissection of the SCZ from other cortical regions (Figure 1A). When non-NSCs from adjacent tissues, such as the cerebral cortex, are cultured with SCZ-aNSCs, catastrophic death occurs, which negatively affects the viability and sphere-formation of SCZ-NSCs16-18,22. The caudal SCZ (2-3 mm posterior to bregma) was confirmed as the best region for generating distinct SCZ-aNSCs. Second, the appropriate enzymatic treatment in the harvesting and passaging steps is critical for achieving a high yield of cells. Dispase II and papain were more effective for isolating aNSCs than trypsin. Dissociation of cells for passaging with dissociation buffer instead of trypsin enhanced their viability19. Mechanical dissociation and trituration with a pipette should be minimal. Third, a cell strainer is generally used in primary culture systems to remove cellular debris after tissue digestion. However, due to the localization of SCZ-aNSCs, these cells are obtained after the breakage of white matter by enzyme digestion and mechanical trituration. During filtration with a cell strainer, a substantial amount of cells would be lost. Therefore, culturing SCZ-aNSCs without using a cell strainer is a better way to get a high yield of cells.
While both neurosphere cultures and monolayer cultures can be applied to the maintenance of NSCs, one limitation of the neurosphere culture is that single NSCs dissociated after splitting can be randomly aggregated. The aggregation results in different sizes of neurospheres. When the size of a neurosphere reaches a certain critical value, the neurosphere grows as a heterogeneous structure, due to a lack of nutrients, growth factors, and oxygen at the core20. Furthermore, neurospheres with large sizes are not easily dissociated with dissociation buffer and require longer enzymatic treatment times with extensive mechanical trituration, leading to lower cell viability. Therefore, the monolayer culture system is recommended to maintain SCZ-aNSCs through multiple passages. In a monolayer culture system, aNSCs are stably maintained as NSCs (type B) without spontaneous differentiation into specified cells, such as progenitors (types C and A) (Figure 3A). SCZ-aNSCs were passaged for extended periods, <5 passages in a neurosphere format and >10 passages as a monolayer. This is consistent with previous results, which suggest that the monolayer culture system maintains NSCs in vitro in long-term cultures21. However, the proliferating speed decreased, and the portion of dying cells increased over 5 passages. Extended passaging affects the multipotency and neuronal differentiation with increased chromosome aberration22. Therefore, to avoid extended passaging effects, it is recommended to use early passage (<passage 5) cells for proliferation and differentiation analysis. Although the potential for self-renewal of SCZ-aNSCs is similar to SVZ-aNSCs, less neuronal differentiation was shown in SCZ-aNSCs9.
Methods for isolating aNSCs from neurogenic regions of the adult brain, including the SVZ and dentate gyrus (DG), have been established22. Although such protocols have promoted the isolation and cultivation of aNSCs in vitro, there are several limitations to obtaining a high number of cells. Many protocols utilize a brain tissue chopper that may cause the loss of brain tissue during the chopping procedure. Another approach to isolate aNSCs from neurogenic regions uses a coronal cut through the brain using a scalpel. This is followed by the micro-dissection of the SVZ or of the DG along the longitudinal fissure23. The presence of other brain regions can cause other cell types to contaminate the aNSC culture, which might affect the viability of the cells in vitro. With the current protocol, many different samples can be managed in a single experiment, including controls versus a variety of experimental groups. Also, slicing using a brain matrix is superior to a brain chopping tool, as it allows for the attainment of NSCs from various brain regions with a high cell yield. It also enables the comparison of aNSCs from different regions of the same brain.
Transplantation and engineering of endogenous NSCs have been considered as possible strategies for stem cell therapy. For this, in vitro studies about the characteristics of aNSCs should also be comprehensively explored. Therefore, the establishment of a well-characterized in vitro culture system will be helpful for furthering the application of NSCs. In this culture system, the stem-cell properties of SCZ-aNSCs were well-maintained, as evidenced by self-renewal and multiple-lineage differentiation under the appropriate conditions. Therefore, this culture system can be used for the expansion of SCZ-aNSCs for biological studies and therapeutic applications.
The authors have nothing to disclose.
This work was supported by the Brain Research Program through the National Research Foundation (NRF), funded by the Korean Ministry of Science, ICT, and Future Planning (Grants NRF-2015M3C7A1028790); and by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI14C3347).
Medium components | |||
DMEM/F12 | Gibco | 11320-033 | +L-glutamin, +Sodium bicarbonate |
Pen/Strep | Invitrogen | 15140-122 | |
N2 supplement | Gibco | 17502-048 | |
B27 supplement | Gibco | 17504-044 | |
Growth factor | |||
bFGF | R&D | 233-FB | |
EGF | Gibco | PHG0313 | |
Buffer | |||
PBS (10X) | BIOSOLUTION | BP007a | 1X dilution |
HBSS | Gibco | 14175-095 | |
Dissociattion buffer | |||
Dispase II | Roche | 04-942-078-001 | |
Papain | Worthington | 3126 | |
Accutase | ICT | AT-104 | |
Tool | |||
Fine forceps | WPI | 555229F | |
Scissors | Storz | E3321-C | |
Brain matrix (1mm) | RWD | 68707 | |
Double-edged razor | DORCO | ST-300 | |
30 gage needle | SUNGSHIM | N1300 | |
Materials | |||
15 ml tubes | SPL | 50015 | |
50 ml tubes | SPL | 50050 | |
35mm dish | SPL | 10035 | petridish |
100mm dish | SPL | 10090 | petridish |
Cover slip (18mm) | Deckglaser | 111580 | |
12 well dish | SPL | 32012 | non-coating |
6 well dish | SPL | 32006 | non-coating |
Coating materials | |||
PLO | Sigma | P4957 | 0.01% |
Laminin | Gibco | 23017-015 | 10 mg/ml |
Primary antibodies | |||
Nestin | Millipore | MAB353 | mouse (1:1000) |
EGFR | Abcam | ab2430 | rabbit (1:1000) |
DCX | Santa Cruz | SC8066 | goat (1:500) |
Tuj1 | Sigma | T2200 | rabbit (1:2000) |
GFAP | Invitrogen | 13-0300 | rat (1:1000) |
O4 | Millipore | MAB345 | mouse (1:500) |
BrdU | Abcam | ab6326 | Rat (1:500) |
Secondary antibodies | |||
anti-mouse 488 | Invitrogen | A21202 | 1:500 |
anti-mouse cy3 | Jackson | 715-165-151 | |
anti-mouse 647 | Jackson | 715-606-150 | |
anti-rabbit 488 | Alexa | A21206 | |
anti-rabbit cy3 | Jackson | 711-165-152 | |
anti-rabbit 647 | Jackson | 711-605-152 | |
anti-goat 488 | Alexa | A11055 | |
anti-goat cy3 | Jackson | 705-165-147 | |
anti-goat 647 | Invitrogen | A21447 | |
anti-rat 488 | Invitrogen | A21208 | |
anti-rat cy3 | Jackson | 712-166-150 | |
anti-rat 647 | Jackson | 712-605-153 | |
Immunostaining materials | |||
BSA | Millipore | 82-100-6 | 3% BSA with 0.1% Triton X-100 in PBS |
Triton X-100 | usb | 22686 | |
4% PFA | Biosesang | P2031 | |
Hoechest33342 | Life Technology | H3570 | Dye for staining nuclei |